Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

EMT inducers catalyze malignant transformation of mammary epithelial cells and drive tumorigenesis towards claudin-low tumors in transgenic mice.

Morel AP, Hinkal GW, Thomas C, Fauvet F, Courtois-Cox S, Wierinckx A, Devouassoux-Shisheboran M, Treilleux I, Tissier A, Gras B, Pourchet J, Puisieux I, Browne GJ, Spicer DB, Lachuer J, Ansieau S, Puisieux A.

PLoS Genet. 2012;8(5):e1002723. doi: 10.1371/journal.pgen.1002723. Epub 2012 May 24.

2.

The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.

Taylor MA, Parvani JG, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):169-90. doi: 10.1007/s10911-010-9181-1. Epub 2010 May 15. Review.

3.

Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression.

May CD, Sphyris N, Evans KW, Werden SJ, Guo W, Mani SA.

Breast Cancer Res. 2011 Feb 8;13(1):202. doi: 10.1186/bcr2789. Review.

4.

Oncogenic roles of EMT-inducing transcription factors.

Puisieux A, Brabletz T, Caramel J.

Nat Cell Biol. 2014 Jun;16(6):488-94. doi: 10.1038/ncb2976. Review.

PMID:
24875735
5.

ZEB proteins link cell motility with cell cycle control and cell survival in cancer.

Browne G, Sayan AE, Tulchinsky E.

Cell Cycle. 2010 Mar 1;9(5):886-91. Epub 2010 Mar 3. Review.

PMID:
20160487
6.

ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.

Hill L, Browne G, Tulchinsky E.

Int J Cancer. 2013 Feb 15;132(4):745-54. doi: 10.1002/ijc.27708. Epub 2012 Jul 21. Review.

7.

Role of Cripto-1 during epithelial-to-mesenchymal transition in development and cancer.

Rangel MC, Karasawa H, Castro NP, Nagaoka T, Salomon DS, Bianco C.

Am J Pathol. 2012 Jun;180(6):2188-200. doi: 10.1016/j.ajpath.2012.02.031. Epub 2012 Apr 26. Review.

8.

Noncanonical TGF-╬▓ signaling during mammary tumorigenesis.

Parvani JG, Taylor MA, Schiemann WP.

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):127-46. doi: 10.1007/s10911-011-9207-3. Epub 2011 Mar 31. Review.

9.

microRNAs and EMT in mammary cells and breast cancer.

Wright JA, Richer JK, Goodall GJ.

J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):213-23. doi: 10.1007/s10911-010-9183-z. Epub 2010 May 25. Review.

PMID:
20499142
10.

Therapeutic Targeting of Epithelial Plasticity Programs: Focus on the Epithelial-Mesenchymal Transition.

Malek R, Wang H, Taparra K, Tran PT.

Cells Tissues Organs. 2017;203(2):114-127. doi: 10.1159/000447238. Epub 2017 Feb 20. Review.

11.

Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness.

Olivos DJ, Mayo LD.

Int J Mol Sci. 2016 Nov 26;17(12). pii: E1982. Review.

12.

EMT- and MET-related processes in nonepithelial tumors: importance for disease progression, prognosis, and therapeutic opportunities.

Kahlert UD, Joseph JV, Kruyt FAE.

Mol Oncol. 2017 Jul;11(7):860-877. doi: 10.1002/1878-0261.12085. Epub 2017 Jun 19. Review.

13.

SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?

Louren├žo AR, Coffer PJ.

Trends Cancer. 2017 Aug;3(8):571-582. doi: 10.1016/j.trecan.2017.06.002. Epub 2017 Jul 8. Review.

PMID:
28780934

Supplemental Content

Support Center